BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32248600)

  • 1. Overexpression of miR-199/214 is a distinctive feature of iron-induced and asbestos-induced sarcomatoid mesothelioma in rats.
    Okazaki Y; Chew SH; Nagai H; Yamashita Y; Ohara H; Jiang L; Akatsuka S; Takahashi T; Toyokuni S
    Cancer Sci; 2020 Jun; 111(6):2016-2027. PubMed ID: 32248600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma.
    Hu Q; Akatsuka S; Yamashita Y; Ohara H; Nagai H; Okazaki Y; Takahashi T; Toyokuni S
    Lab Invest; 2010 Mar; 90(3):360-73. PubMed ID: 20065947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron overload signature in chrysotile-induced malignant mesothelioma.
    Jiang L; Akatsuka S; Nagai H; Chew SH; Ohara H; Okazaki Y; Yamashita Y; Yoshikawa Y; Yasui H; Ikuta K; Sasaki K; Kohgo Y; Hirano S; Shinohara Y; Kohyama N; Takahashi T; Toyokuni S
    J Pathol; 2012 Nov; 228(3):366-77. PubMed ID: 22864872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Susceptibility of Human Pleural and Peritoneal Mesothelial Cells to Asbestos Exposure.
    Dragon J; Thompson J; MacPherson M; Shukla A
    J Cell Biochem; 2015 Aug; 116(8):1540-52. PubMed ID: 25757056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model.
    Minami D; Takigawa N; Kato Y; Kudo K; Isozaki H; Hashida S; Harada D; Ochi N; Fujii M; Kubo T; Ohashi K; Sato A; Tanaka T; Hotta K; Tabata M; Toyooka S; Tanimoto M; Kiura K
    Cancer Sci; 2015 Oct; 106(10):1296-302. PubMed ID: 26211743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent homozygous deletion of Cdkn2a/2b in tremolite-induced malignant mesothelioma in rats.
    Okazaki Y; Misawa N; Akatsuka S; Kohyama N; Sekido Y; Takahashi T; Toyokuni S
    Cancer Sci; 2020 Apr; 111(4):1180-1192. PubMed ID: 32080953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention.
    Toyokuni S
    Free Radic Biol Med; 2019 Mar; 133():206-215. PubMed ID: 30312759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas.
    Leblay N; Leprêtre F; Le Stang N; Gautier-Stein A; Villeneuve L; Isaac S; Maillet D; Galateau-Sallé F; Villenet C; Sebda S; Goracci A; Byrnes G; McKay JD; Figeac M; Glehen O; Gilly FN; Foll M; Fernandez-Cuesta L; Brevet M
    J Thorac Oncol; 2017 Apr; 12(4):724-733. PubMed ID: 28034829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion.
    Ak G; Tomaszek SC; Kosari F; Metintas M; Jett JR; Metintas S; Yildirim H; Dundar E; Dong J; Aubry MC; Wigle DA; Thomas CF
    Biomed Res Int; 2015; 2015():635748. PubMed ID: 25756049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of malignant peritoneal mesothelioma without asbestos exposure: cytologic and immunohistochemical features.
    Kinoshita Y; Takasu K; Yuri T; Yoshizawa K; Uehara N; Kimura A; Miki H; Tsubura A; Shikata N
    Ann Diagn Pathol; 2013 Feb; 17(1):99-103. PubMed ID: 22784439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant peritoneal mesotheliomas of rats induced by multiwalled carbon nanotubes and amosite asbestos: transcriptome and epigenetic profiles.
    Reamon-Buettner SM; Rittinghausen S; Klauke A; Hiemisch A; Ziemann C
    Part Fibre Toxicol; 2024 Jan; 21(1):3. PubMed ID: 38297314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asbestos-induced mesothelial injury and carcinogenesis: Involvement of iron and reactive oxygen species.
    Okazaki Y
    Pathol Int; 2022 Feb; 72(2):83-95. PubMed ID: 34965001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-1 induces growth arrest and apoptosis in malignant mesothelioma.
    Xu Y; Zheng M; Merritt RE; Shrager JB; Wakelee HA; Kratzke RA; Hoang CD
    Chest; 2013 Nov; 144(5):1632-1643. PubMed ID: 23828229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.
    Micolucci L; Akhtar MM; Olivieri F; Rippo MR; Procopio AD
    Oncotarget; 2016 Sep; 7(36):58606-58637. PubMed ID: 27259231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
    Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
    Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
    Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
    Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition in malignant mesothelioma.
    Fassina A; Cappellesso R; Guzzardo V; Dalla Via L; Piccolo S; Ventura L; Fassan M
    Mod Pathol; 2012 Jan; 25(1):86-99. PubMed ID: 21983934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant Mesothelioma and Its Non-Asbestos Causes.
    Attanoos RL; Churg A; Galateau-Salle F; Gibbs AR; Roggli VL
    Arch Pathol Lab Med; 2018 Jun; 142(6):753-760. PubMed ID: 29480760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.
    Joseph NM; Chen YY; Nasr A; Yeh I; Talevich E; Onodera C; Bastian BC; Rabban JT; Garg K; Zaloudek C; Solomon DA
    Mod Pathol; 2017 Feb; 30(2):246-254. PubMed ID: 27813512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin expression and organization in mesothelial and mesothelioma cells.
    Ferriola PC; Stewart W
    Am J Physiol; 1996 Nov; 271(5 Pt 1):L804-12. PubMed ID: 8944724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.